Sharechat Logo

Ponzi schemer Ross to challenge 10 year, 10 month sentence report

Monday 16th December 2013

Text too small?

Convicted Ponzi scheme perpetrator David Ross is to appeal against his sentence of 10 years and 10 months, claiming it is "manifestly excessive".

Fairfax Media reports confirmation of the appeal from Ross's Wellington barrister, Gary Turkington, who did not immediately return calls for confirmation.

Wellington-based Ross built up a private investment service by word of mouth, producing regular reports for shareholders indicating healthy but fictitious returns.

A spokesman for some 1,200 investors defrauded of around $115 million, Bruce Tichbon, was also not immediately available for comment.

Between June 2000 and September 2012, Ross reported false profits of $351 million from fictitious securities trading.

The appeal is expected to be heard in April or May next year, the reports say.

Ross is destined to serve a non-parole period of five years and five months under his current sentence, which Turkington reportedly says will be contested either on the grounds of its being "manifestly excessive" or "inappropriate."

The fraud was the largest single such crime committed by an individual in New Zealand, and preyed on many wealthy lower North Island investors.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report